Recent mapping of acute intermittent porphyria (AIP) in Sweden has Drugs contraindicated in acute porphyria (Läkemedel farliga vid akut porfyri), jointly. Pathogenesis and treatment of acute intermittent porphyria. R D Forrest [ PubMed]; Lithner F. Intravenös hematinbehandling av akut intermittent porfyri. All porphyrias result from partial deficiency of one of the enzymes of heme biosynthesis and, apart from the sporadic form of porphyria cutanea tarda, are.
|Published (Last):||14 January 2010|
|PDF File Size:||11.44 Mb|
|ePub File Size:||8.11 Mb|
|Price:||Free* [*Free Regsitration Required]|
Hepatocellular carcinoma without cirrhosis: The cause of hyponatremia is not clear; both SIADH syndrome of inappropriate antidiuretic intermitgant release and renal salt wasting have been proposed as mechanisms.
Acute intermittent porphyria
GeneReviews Advanced Search Help. Porphyrias are caused by mutations in genes that encode enzymes in heme synthesis. Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis.
Attacks may be complicated by neurologic findings mental changes, convulsions, and peripheral neuropathy that may progress to respiratory paralysisand hyponatremia. Assure that adequate nutrition is provided by a normal balanced diet.
There are frequently secondary causes of dyslipidaemias, often reversible. No recent formal study has been performed, but informal feedback from experienced clinicians at international porphyria meetings indicates that few patients have benefited from this treatment.
Acute intermittent porphyria can be precipitated by conditions that increase hepatic heme synthesis such as medications, stress, starvation, severe illness, infection, surgery, smoking, and alcohol.
Treatment of acute akit. Penetrance The penetrance for clinical manifestations of an HMBS pathogenic variant is not accurately known. The main exception is Sweden where the prevalence of AIP is high 1 per people in northern Sweden due to a founder effect.
Specific treatment should be started as soon as the diagnosis is established unless the attack is mild and clearly resolving. Demonstration that an increased PBG concentration is caused by AIP requires exclusion of other acute kntermittant by analysis of porphyrins in stool and plasma.
Treatment of the acute attack
The gene consists of 15 exons distributed over 10 kb that encode a ubiquitous HMBS isoform exons 1 and that is expressed in all tissues [ Puy et al ] and an erythroid isoform exons that is restricted to erythroid cells [ Grandchamp et al ]. Treat pain with opiate analgesia often in large amounts ; support from a pain team may be required.
Avoid drugs and chemicals known to exacerbate porphyria, particularly prescribed medication and over the counter medication. Gilbert’s syndrome Crigler—Najjar syndrome Lucey—Driscoll syndrome. The autosomal dominant acute porphyrias [acute intermittent porphyria AIPvariegate porphyria VP and hereditary coproporphyria HCP ] are characterised by episodic acute neurovisceral attacks which porfiris be life threatening. Support Center Support Center.
In the summary of the product characteristics, it is recommended that the concentrated heme arginate solution should be mixed with mL physiological saline in a glass container immediately before infusion into a large peripheral vein or through a central venous line over mins. The diagnosis of AIP in a symptomatic individual is based on increased PBG in a random urine sample protected from light prior to analysistogether with evidence of a normal total fecal porphyrin or normal coproporphyrin isomer ratio, and plasma porphyrin fluorescence emission scan that is either normal or shows a peak emission around nm.
The clinical presentation of AIP is highly variable and non-specific. Cutaneous manifestations of porphyria do not occur in AIP. The minimum effective infusion frequency should be employed, usually a weekly dose of hemin infused via an in-dwelling venous catheter. Pathogenesis Two major hypotheses for the pathogenesis of the neurologic lesions that give rise to the clinical features of acute porphyria have been proposed: Increase mainly indicates in vitro condensation of PBG to uroporphyrins.
Some individuals may be more likely to develop paresis based on increased susceptibility of neurons to toxins. Making diagnosis even more difficult was the fact that Jill did not produce the hallmark purple urine during attacks—and that she is adopted.
Acute Intermittent Porphyria – GeneReviews® – NCBI Bookshelf
Nausea, vomiting, constipation, tachycardia, and hypertension are common. Dubin—Johnson syndrome Rotor syndrome. X-linked sideroblastic anemia and the porphyrias. The most common identified triggers for acute attacks are medications, weight loss dietsand surgery.
Stop medications that can exacerbate AIP; provide adequate caloric intake by intravenous infusion if required hypotonic dextrose water solutions should be avoided. Measurement of erythrocyte HMBS activity is less sensitive but may be useful for the few families in which an HMBS pathogenic variant cannot be identified or when molecular testing is unavailable.
Considerations in families with an apparent de novo pathogenic variant. Mortality directly related to acute attacks is now very rare in most countries as a result of improved treatment use of human hemin and identification and counseling of presymptomatic relatives. Prevention of secondary complications: It functions as a monomer localized within the cytoplasm where it catalyzes the synthesis of the linear tetrapyrrole hydroxymethlbilane from four molecules of porphobilinogen [ Anderson et al ].
Prevention of Primary Manifestations To prevent acute attacks patients are advised on the potential triggers as follows: Onset typically occurs in the third or fourth decade [ Anderson et alElder et al ]. Total fecal porphyrin concentration or coproporphyrin isomer ratio is normal. Total urinary porphyrin, but not PBG, concentration may be increased in various disorders, including alcohol abuse and liver disease [ Badminton et al ].
Fitzpatrick’s Dermatology in General Medicine, 5th edn.
Brit J Dermatol ; Connect Socially f t p y r.